Coloplast Cuts Annual Organic Revenue Growth Outlook to 5–7% Through 2030
Coloplast lowered its annual organic revenue growth outlook through 2030 from 7–8% to 5–7%.
Related stories
Coca-Cola Shares Hit 52-year High
Coca-Cola shares increased to 95.38 USD, the highest since July 1974. Over the past 4 weeks, Coca-Cola gained 10.21%, and in the last 12 months, it increased 40.27%.
L impact | EQUITY | Nov 02, 2026, 05:27 PM UTC
Airline Shares Rebound as Crude Oil Prices Fall
Major airline shares rose Monday as crude prices fell sharply. JetBlue gained nearly 11% by midday, while Alaska Airlines rose 9%.
M impact | EQUITY | Nov 02, 2026, 05:27 PM UTC
Snap Settles With Two Teens During Los Angeles Trial
Snap Inc. settled with two teenagers during a Los Angeles trial over social media harms.
L impact | EQUITY | Nov 02, 2026, 05:26 PM UTC
BofA Sees Continued Recovery at CubeSmart and Self-Storage REITs
BofA said CubeSmart and other self-storage REITs signaled continued recovery following third-quarter results.
M impact | EQUITY | Nov 02, 2026, 05:22 PM UTC
Information Services Group Reports Third-Quarter 2026 Results
Revenue was $65.1 million, up 4.4% from $62.4 million a year earlier. Net income rose to $3.4 million from $3.1 million, and diluted EPS increased to $0.07 from $0.06.
M impact | EQUITY | Nov 02, 2026, 05:21 PM UTC
Velocity Capital Management Acquires Stakes in LV8 and Mirage
The investment backs founder and CEO Griffin Haddrill and pairs LV8’s social-first brand agency with Mirage.
M impact | EQUITY | Nov 02, 2026, 05:21 PM UTC